Women Focused Novel Therapeutics

Innovating with Nature

Women Focused Novel Therapeutics

Innovating with Nature

25+

Years

of experience addressing Women’s Health issues, allowing us to focus on how gender specific mechanisms lead to diseases in women.

Drug Prospect
Imagine a DRUG that

treats menopausal hot flashes & prevents breast cancer

Market Size:

50 million USA, 1.1 billion world-wide
$10 billion annual market potential

Drug Prospect
Imagine a DRUG that

treats menopausal hot flashes & prevents breast cancer

Market Size:

50 million USA, 1.1 billion world-wide
$10 billion annual market potential

We address

Women’s Health Issues
We strive to become

a leading company focused on diseases encountered by Women.

We harness specific and selective targets to address women’s diseases.

The company’s targets include:

  • nuclear receptors and
  • metabolic regulators

involved in multiple women’s cancers, autoimmune diseases and gynecological disorders

The latest

Publications

Estrogen Receptor Binds to and Regulates Three Distinct Classes of Target Genes

Estrogen Receptor Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

Tissue-Specific Regulation of Genes by Estrogen Receptors

Regulation of specific target genes and biological responses by estrogen receptor subtype agonists

Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer

A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer